A risk nomogram of COVID-19 infection in cancer patients

Curr Probl Cancer. 2021 Apr;45(2):100645. doi: 10.1016/j.currproblcancer.2020.100645. Epub 2020 Aug 27.

Authors

Yuan Li¹, Long Wu¹, Ci Zhao¹, Qinglan Wang¹, Junjie Ye¹, Chengliang Zhu², Weiping Tao³

Affiliations

¹ Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China.
² Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
³ Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: taowpwp@sina.com.

PMID: 33160680
PMCID: PMC7451093
DOI: 10.1016/j.currproblcancer.2020.100645

No abstract available

MeSH terms

Adult
Age Factors
Aged
Aged, 80 and over
COVID-19 / diagnosis
COVID-19 / etiology*
China
Clinical Decision Rules*
Female
Humans
Logistic Models
Male
Middle Aged
Neoplasms / complications*
Nomograms*
Risk Assessment
Risk Factors